ArticleJournal of cardiothoracic surgery2026
Clinical characteristics of ground-glass opacities in young patients : a single-center retrospective study.
Article in Journal of cardiothoracic surgery, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectivesPulmonary ground-glass opacities (GGOs) are increasingly being detected through screening in younger patients, this study aimed to characterize the features of young patients with GGOs.
methodsPatients aged ≤ 55 years who underwent surgical treatment for GGOs at Tongji Hospital of Wuhan from August 2018 to July 2021 were retrospectively analyzed. Clinical and pathological data were collected and compared between age groups.
resultsAmong 1,283 patients, 70.1% were female and 87.0% were nonsmokers. Patients were divided into a young group (18–45 years) and a middle-aged group (46–55 years). Compared with the middle-aged group, young patients had a higher proportion of incidental cases detected during health check-ups (74.6% vs. 66.7%), fewer underlying diseases (2.7% vs. 15.3%), and a lower prevalence of family history of tumors (17.9% vs. 27.6%). Their GGOs were smaller (median 9 mm vs. 10 mm) and more often pure (77.2% vs. 67.0%), with higher rates of adenomatous hyperplasia (4.2% vs. 3.2%), adenocarcinoma in situ (24.3% vs. 19.8%), and minimally invasive adenocarcinoma (34.5% vs. 28.0%). A greater proportion of stage 0 and stage IA1 lesions was also observed (83.0% vs. 70.7%). Wedge resection and segmentectomy were performed more frequently in the young group, whereas lobectomy was less common. The EGFR mutation rate was also lower (47.5% vs. 75.5%).
conclusionsAn increasing number of patients under the age of 46 with GGO have been diagnosed with early-stage lung cancer during their medical examinations, but most of them do not have risk factors. Young patients exhibit distinct imaging, pathological, surgical, and genetic characteristics, underscoring the need for further large-scale studies. CLINICAL REGISTRATION NUMBER: TJ-IRB20221294.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.